Spravato (esketamine) is a breakthrough nasal spray treatment that works differently than traditional antidepressants to provide relief where others haven't.
FDA Approved
Safe & Effective Treatment
For many, traditional oral antidepressants simply aren't enough. When two or more medications have failed to provide relief, you may be suffering from Treatment-Resistant Depression (TRD). Spravato® (esketamine) offers a revolutionary new path forward.
Spravato is the first FDA-approved nasal spray for TRD. Unlike traditional antidepressants that target serotonin or norepinephrine, Spravato targets the glutamate system to rapidly repair damaged neural connections and restore brain function.
Many patients experience a significant reduction in depressive symptoms within hours or days, rather than weeks.
Works on the brain's most abundant neurotransmitter to rebuild synapses directly.
Administered in our safe, comfortable clinic under professional medical monitoring for your peace of mind.
Spravato is covered by most major insurance plans, including Medicare, for eligible patients with TRD.
Board-Certified Psychiatrist specializing in Treatment-Resistant Depression and Advanced TMS Therapy.
With extensive clinical experience, Dr. Amin is dedicated to providing compassionate, evidence-based care. His personal philosophy centers around treating the whole person, not just the symptoms, ensuring each patient receives a tailored approach to their mental wellness.
Hear from patients whose lives were transformed through Dr. Amin's care.
Find quick answers to some of the most common questions our patients ask about this treatment.
You will self-administer the nasal spray in our office under the supervision of a healthcare provider. You'll then stay in a comfortable, private room for about two hours for monitoring while the medication takes effect.
Spravato (esketamine) is a chemical cousin of ketamine. It is FDA-approved specifically for depression and is administered through a nasal spray, whereas clinical ketamine is usually given via IV infusion.
No. Because of potential sedation or dissociation, you must arrange for a ride home and should not drive or operate heavy machinery until the next day.
Typically, patients start with sessions twice a week for the first month, then transition to once a week for the second month, followed by a maintenance schedule tailored to your needs.
Contact Dr. Amin's clinic today. Schedule an in-depth consultation to see if this treatment is right for you, and begin your journey to recovery.
Book Your Evaluation